Hospital
Palm Beach Gardens Community Hospital, INC.
Palm Beach Gardens Community Hospital, INC. was paid $3.17M by Medicaid between Jan 2018 and Nov 2024, across 111 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.
33Billing provider infoPALM BEACH GARDENS COMMUNITY HOSPITAL, INC.
PALM BEACH GARDENS, FL 33410
PALM BEACH GARDENS, FL 33410
33aNPI1144251216assigned 07/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.17M
24GClaims139,835
24DCodes billed111
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#106 of 163
Median peer was paid$4.77M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,440 | $199K | |
| 2019 | 32,271 | $394K | |
| 2020 | 25,100 | $371K | |
| 2021 | 30,422 | $651K | |
| 2022 | 26,030 | $1.01M | |
| 2023 | 10,980 | $442K | |
| 2024incomplete | 2,592 | $105K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 7,245 | 5,898 | $533K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 7,072 | 5,466 | $516K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 5,347 | 4,390 | $496K |
| 80053 | Comprehensive metabolic panel | 6.8% | 8,348 | 6,159 | $217K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.5% | 1,323 | 1,072 | $207K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.5% | 551 | 485 | $205K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.1% | 3,539 | 2,411 | $161K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.3% | 3,882 | 2,793 | $106K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.3% | 520 | 442 | $104K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 2,427 | 1,313 | $75K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.4% | 1,654 | 1,301 | $75K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.3% | 937 | 797 | $72K |
99 more codes
| S0028 | Injection, famotidine, 20 mg | 1.0% | 332 | $32K |
| 81001 | <1% | 4,571 | $22K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 712 | $21K |
| G0378 | Hospital observation service, per hour | <1% | 2,209 | $19K |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 565 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 455 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,729 | $15K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,172 | $14K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 652 | $14K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 684 | $13K |
| A9270 | Non-covered item or service | <1% | 1,979 | $12K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,879 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,453 | $12K |
| 87070 | <1% | 842 | $12K | |
| 84703 | <1% | 3,466 | $12K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 912 | $11K |
| 85027 | <1% | 3,356 | $11K | |
| 85610 | <1% | 1,736 | $9K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,426 | $9K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,334 | $9K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 347 | $8K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 15 | $8K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 15 | $8K |
| 84484 | <1% | 3,219 | $7K | |
| 82962 | <1% | 1,789 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,182 | $6K |
| J3490 | Unclassified drugs | <1% | 106 | $5K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 792 | $5K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 748 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,031 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 558 | $5K |
| 80076 | <1% | 209 | $4K | |
| 85730 | <1% | 1,225 | $4K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,508 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,306 | $4K |
| J2704 | Injection, propofol, 10 mg | <1% | 365 | $3K |
| 83880 | <1% | 503 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 105 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 295 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,018 | $2K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 345 | $2K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 39 | $2K |
| 82550 | <1% | 1,802 | $2K | |
| 85379 | <1% | 406 | $2K | |
| 83690 | <1% | 2,410 | $1K | |
| 96376 | <1% | 919 | $1K | |
| 87430 | <1% | 763 | $847.67 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,108 | $815.90 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 419 | $796.22 |
| 83735 | <1% | 1,061 | $699.71 | |
| 87040 | <1% | 289 | $634.54 | |
| 82374 | <1% | 297 | $620.56 | |
| 93307 | <1% | 19 | $617.54 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 412 | $591.62 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,520 | $492.85 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 123 | $475.28 |
| C1769 | Guide wire | <1% | 154 | $475.28 |
| 82565 | <1% | 366 | $379.76 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 99 | $349.08 |
| 84295 | <1% | 287 | $293.20 | |
| 84520 | <1% | 350 | $293.20 | |
| 82947 | <1% | 296 | $293.20 | |
| 82435 | <1% | 287 | $293.20 | |
| 84132 | <1% | 322 | $293.20 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 28 | $276.75 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 344 | $210.71 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 166 | $205.56 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 17 | $196.27 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 938 | $192.89 |
| 93976 | <1% | 44 | $173.28 | |
| 87088 | <1% | 170 | $132.19 | |
| 93970 | <1% | 15 | $130.85 | |
| 86850 | <1% | 190 | $114.42 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 32 | $89.96 |
| 86900 | <1% | 192 | $83.16 | |
| 99001 | <1% | 221 | $75.73 | |
| 86901 | <1% | 192 | $54.15 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 45 | $43.48 |
| 87186 | <1% | 204 | $21.21 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 182 | $20.41 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 79 | $12.47 |
| 87210 | <1% | 45 | $5.22 | |
| 74022 | <1% | 42 | $4.52 | |
| 84100 | 0% | 86 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 112 | $0.00 |
| 87076 | 0% | 80 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 48 | $0.00 |
| 84702 | 0% | 94 | $0.00 | |
| 99152 | 0% | 20 | $0.00 | |
| 87077 | 0% | 15 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 131 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 70 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 0% | 16 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 32 | $0.00 |
| 83605 | 0% | 113 | $0.00 | |
| 93971 | 0% | 41 | $0.00 | |
| 82607 | 0% | 43 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 36 | $0.00 |
| 82746 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOLE, KIM (CFO)
| Provider | Location | Paid |
|---|---|---|
| West Boca Medical Center, INC. | Boca Raton, FL | $13.41M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.